(NASDAQ: FEMY) Femasys's forecast annual revenue growth rate of 224.86% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 11.6%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.68%.
Femasys's revenue in 2025 is $1,260,643.On average, 2 Wall Street analysts forecast FEMY's revenue for 2025 to be $215,245,599, with the lowest FEMY revenue forecast at $210,665,906, and the highest FEMY revenue forecast at $219,825,293. On average, 1 Wall Street analysts forecast FEMY's revenue for 2026 to be $551,853,079, with the lowest FEMY revenue forecast at $551,853,079, and the highest FEMY revenue forecast at $551,853,079.
In 2027, FEMY is forecast to generate $1,012,112,286 in revenue, with the lowest revenue forecast at $1,012,112,286 and the highest revenue forecast at $1,012,112,286.